PATENT CLAIM ANALYSIS

Application Number: 15863773
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "001000"]

Abstract:
The present disclosure provides compounds and methods useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

Claim (Index 26):
The method of  claim 25 , wherein the ApoE-associated neurodegenerative disorder is AD, vascular cognitive impairment, cerebral amyloid angiopathy, traumatic brain injury, or multiple sclerosis.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 86.0
- Lexical Diversity: 1.32258
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10566857', '14790313', '10901563', '14776184', '13238081']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7780337432268263
- 35 USC 102 Novelty (BERT): 0.5207105233924563
- Combined Prediction Score: 0.7523014212433893
- Mean Citation Score: 300.7376799999999
- Max Citation Score: 312.52133
- Similarity Product: 217.1660911937117

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test